Connect Biopharma (CNTB) Short Interest Ratio & Short Volume $0.82 -0.03 (-3.96%) Closing price 05/21/2025 03:59 PM EasternExtended Trading$0.80 -0.01 (-1.84%) As of 05/21/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Connect Biopharma Short Interest DataConnect Biopharma (CNTB) has a short interest of 48,500 shares. This marks a -25.38% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.5, indicating that it would take 0.5 days of the average trading volume of 55,771 shares to cover all short positions.Current Short Interest48,500 sharesPrevious Short Interest65,000 sharesChange Vs. Previous Month-25.38%Dollar Volume Sold Short$39,847.60Short Interest Ratio0.5 Days to CoverLast Record DateApril 30, 2025Outstanding Shares55,349,000 sharesPercentage of Shares Shorted0.09%Today's Trading Volume78,482 sharesAverage Trading Volume55,771 sharesToday's Volume Vs. Average141% Short Selling Connect Biopharma? Sign up to receive the latest short interest report for Connect Biopharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCNTB Short Interest Over TimeCNTB Days to Cover Over TimeCNTB Percentage of Float Shorted Over Time Connect Biopharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202548,500 shares $39,847.60 -25.4%N/A0.5 $0.82 4/15/202565,000 shares $53,943.50 +1,103.7%0.2%0.7 $0.83 3/31/20255,400 shares $2,970.00 -47.6%0.0%0.1 $0.55 3/15/202510,300 shares $8,817.83 -77.9%0.0%0.5 $0.86 2/28/202546,700 shares $42,170.10 +56.7%0.1%1.9 $0.90 2/15/202529,800 shares $27,487.52 -4.8%0.1%1.2 $0.92 1/31/202531,300 shares $30,423.60 -23.5%0.1%1.1 $0.97 1/15/202540,900 shares $42,945.00 -44.6%0.1%1.5 $1.05 12/31/202473,800 shares $101,844.00 -16.0%0.1%2.6 $1.38 12/15/202487,800 shares $98,195.52 +53.5%0.2%3.1 $1.12 Get the Latest News and Ratings for CNTB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Connect Biopharma and its competitors with MarketBeat's FREE daily newsletter. 11/30/202457,200 shares $60,632.00 -7.4%0.1%2.2 $1.06 11/15/202461,800 shares $68,598.00 +110.2%0.1%2.1 $1.11 10/31/202429,400 shares $34,104.00 -35.4%0.1%1 $1.16 10/15/202445,500 shares $57,330.00 +26.7%0.1%1.7 $1.26 9/30/202435,900 shares $50,978.00 +60.3%0.1%1.2 $1.42 9/15/202422,400 shares $27,552.00 +5.2%0.0%0.5 $1.23 8/31/202421,300 shares $34,080.00 +76.0%0.0%0.4 $1.60 8/15/202412,100 shares $13,794.00 -9.7%0.0%0.2 $1.14 7/31/202413,400 shares $15,946.00 +24.1%0.0%0.2 $1.19 7/15/202410,800 shares $13,608.00 -30.3%0.0%0.2 $1.26 6/30/202415,500 shares $23,560.00 -44.2%0.0%0.2 $1.52 6/15/202427,800 shares $44,480.00 -21.5%0.1%0.2 $1.60 5/31/202435,400 shares $60,534.00 -34.6%0.1%0.3 $1.71 5/15/202454,100 shares $99,003.00 +73.4%0.1%0.3 $1.83 4/30/202431,200 shares $43,368.00 -62.5%0.1%0.2 $1.39 4/15/202483,100 shares $138,777.00 -28.1%0.2%0.5 $1.67 3/31/2024115,500 shares $200,970.00 +7.5%0.2%0.7 $1.74 3/15/2024107,400 shares $139,620.00 -13.2%0.2%0.8 $1.30 2/29/2024123,700 shares $141,018.00 -2.7%0.2%0.4 $1.14 2/15/2024127,100 shares $153,791.00 -34.8%0.2%0.4 $1.21 1/31/2024194,800 shares $227,916.00 +52.8%0.4%0.5 $1.17 1/15/2024127,500 shares $140,862.00 -21.3%0.2%0.3 $1.10 12/31/2023162,100 shares $191,278.00 -59.8%0.3%0.4 $1.18 12/15/2023403,200 shares $380,540.16 +208.3%0.8%1.1 $0.94 11/30/2023130,800 shares $150,420.00 +476.2%0.3%0.6 $1.15 11/15/202322,700 shares $40,406.00 -22.8%0.0%0.1 $1.78 10/31/202329,400 shares $43,218.00 +88.5%0.1%0.5 $1.47 10/15/202315,600 shares $13,543.92 -40.7%0.0%0.3 $0.87 9/30/202326,300 shares $21,539.70 +250.7%0.1%0.6 $0.82 9/15/20237,500 shares $5,700.75 -13.8%0.0%0.2 $0.76Trump + Musk = AI’s turning point (Ad)Trump may not code… but he knows how to pick winners. And according to insiders, his administration is preparing to fast-track a new class of AI infrastructure tech. Elon Musk has already poured $51 million into it.Chris Rowe just shared the full details in a live presentation… Watch it here before it comes down. 8/31/20238,700 shares $7,184.46 -61.5%0.0%0.2 $0.83 8/15/202322,600 shares $20,358.08 -48.3%0.0%0.1 $0.90 7/31/202343,700 shares $42,389.00 +55.5%0.1%0.1 $0.97 7/15/202328,100 shares $30,348.00 -52.5%0.1%0.1 $1.08 6/30/202359,200 shares $66,896.00 -19.8%0.1%0.2 $1.13 6/15/202373,800 shares $74,538.00 -12.3%0.1%0.2 $1.01 5/31/202384,100 shares $91,147.58 +14.3%0.2%0.1 $1.08 5/15/202373,600 shares $91,256.64 -23.1%0.1%0.2 $1.24 4/30/202395,700 shares $101,920.50 -25.8%0.2%0.3 $1.07 4/15/2023128,900 shares $135,345.00 -14.1%0.2%0.4 $1.05 3/31/2023150,000 shares $149,985.00 +100.8%0.3%0.5 $1.00 3/15/202374,700 shares $83,664.00 -12.2%0.1%0.2 $1.12 2/28/202385,100 shares $109,779.00 -15.0%0.2%1.6 $1.29 2/15/2023100,100 shares $103,103.00 -11.0%0.2%2 $1.03 1/31/2023112,500 shares $138,375.00 -3.5%0.2%2.3 $1.23 1/15/2023116,600 shares $115,317.40 -12.5%0.2%2.3 $0.99 12/30/2022133,200 shares $115,590.96 -58.0%0.3%2.4 $0.87 12/15/2022316,800 shares $275,616.00 -1.2%0.6%2.8 $0.87 11/30/2022320,600 shares $232,531.18 -4.0%0.6%2.8 $0.73 11/15/2022334,000 shares $251,201.40 -8.2%0.6%2.5 $0.75 10/31/2022364,000 shares $316,607.20 -32.0%0.7%2.1 $0.87 10/15/2022535,000 shares $506,003.00 +29.9%1.0%1.7 $0.95 9/30/2022411,900 shares $531,351.00 +2.6%0.8%1.3 $1.29 9/15/2022401,400 shares $586,044.00 -15.7%0.8%1.1 $1.46 8/31/2022476,400 shares $666,960.00 -2.2%0.9%1.2 $1.40 8/15/2022487,100 shares $706,295.00 +1.1%0.9%1.2 $1.45 7/31/2022481,600 shares $392,600.32 +7.6%0.9%1.1 $0.82 7/15/2022447,600 shares $407,316.00 +124.8%0.8%1.1 $0.91 6/30/2022199,100 shares $173,217.00 +7.4%0.4%0.5 $0.87 6/15/2022185,400 shares $133,988.58 -18.0%0.4%0.7 $0.72 5/31/2022226,000 shares $180,800.00 +23.4%N/A0.9 $0.80 5/15/2022183,100 shares $137,325.00 -42.5%N/A0.7 $0.75 4/30/2022318,400 shares $646,352.00 +5.5%N/A1.7 $2.03 4/15/2022301,900 shares $863,434.00 +6.0%N/A3.5 $2.86 3/31/2022284,900 shares $860,398.00 +8.6%N/A2.3 $3.02 3/15/2022262,400 shares $645,504.00 +2.3%N/A1.1 $2.46 2/28/2022256,500 shares $1.01 million +7.1%N/A0.9 $3.92 2/15/2022239,600 shares $1.08 million -24.3%N/A0.7 $4.50 1/31/2022316,600 shares $1.46 million -7.5%0.6%0.7 $4.60 1/15/2022342,400 shares $1.76 million +25.7%N/A0.7 $5.14 12/31/2021272,400 shares $1.40 million +3.6%N/A0.6 $5.15 12/15/2021263,000 shares $1.22 million +533.7%N/A0.8 $4.64 11/30/202141,500 shares $180,525.00 -97.7%N/A0.1 $4.35 11/15/20211,810,000 shares $23.57 million +30.2%N/A7.4 $13.02 10/29/20211,390,000 shares $22.02 million +36.3%N/A15.3 $15.84 10/15/20211,020,000 shares $17.51 million +19.3%N/A13.9 $17.17 9/30/2021855,200 shares $20.72 million +0.1%N/A15.6 $24.23 9/15/2021854,600 shares $18.23 million +0.3%N/A14.2 $21.33 8/31/2021851,700 shares $19.99 million +0.6%N/A13.6 $23.47 8/13/2021846,300 shares $19.90 million No ChangeN/A14.1 $23.51Trump + Musk = AI’s turning point (Ad)Trump may not code… but he knows how to pick winners. And according to insiders, his administration is preparing to fast-track a new class of AI infrastructure tech. Elon Musk has already poured $51 million into it.Chris Rowe just shared the full details in a live presentation… Watch it here before it comes down. CNTB Short Interest - Frequently Asked Questions What is Connect Biopharma's current short interest? Short interest is the volume of Connect Biopharma shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 48,500 shares of CNTB short. Learn More on Connect Biopharma's current short interest. Is Connect Biopharma's short interest increasing or decreasing? Connect Biopharma saw a decrease in short interest in the month of April. As of April 30th, there was short interest totaling 48,500 shares, a decrease of 25.4% from the previous total of 65,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Connect Biopharma's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Connect Biopharma: INmune Bio, Inc. (25.37%), Tiziana Life Sciences Ltd (1.32%), Molecular Partners AG (0.14%), Eledon Pharmaceuticals, Inc. (2.99%), Organigram Holdings Inc. (8.03%), Inhibrx, Inc. (7.27%), ProQR Therapeutics (0.36%), DiaMedica Therapeutics Inc. (1.45%), AC Immune SA (2.25%), Esperion Therapeutics, Inc. (15.33%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short Connect Biopharma stock? Short selling CNTB is an investing strategy that aims to generate trading profit from Connect Biopharma as its price is falling. CNTB shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Connect Biopharma? A short squeeze for Connect Biopharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CNTB, which in turn drives the price of the stock up even further. How often is Connect Biopharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CNTB, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies INMB Short Interest TLSA Short Interest MOLN Short Interest ELDN Short Interest OGI Short Interest INBX Short Interest PRQR Short Interest DMAC Short Interest ACIU Short Interest ESPR Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CNTB) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersWarning: Prepare to Be Shocked by These PayoutsThere's a strategy out there paying up to 70% on tech stocks like Amazon, Tesla, and Microsoft—stocks that don...Investors Alley | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredTrump’s treachery I think Trump’s Treasury Secretary is destroying the stock market on purpose. And no one on Wall Street see...Porter & Company | Sponsored🚨 Nvidia Just Inked a $7B AI Deal—This Could Change EverythingOn Wednesday, Nvidia stock surged—again. Why? Because Saudi Arabia just announced a multi-billion-dollar AI...Timothy Sykes | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Connect Biopharma Holdings Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Connect Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CNTB Stock Free CNTB Stock Alerts